Trending Now
Invesco QQQ Trust Series 1 (QQQ) surges giving bulls a psychological...
The market was in risk off mode yesterday, but the buyers have stepped back in this morning in the QQQ’s. I don’t...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Precision BioSciences Inc. (NASDAQ:DTIL) Receives Fast Track Designation For PBCAR269A For...
Precision BioSciences Inc. (NASDAQ:DTIL) has announced that it has received Fast Track Designation from the FDA for PBCAR269A in treating refractory/relapsed multiple myeloma.
Fast Track...
MAKE IT MODERN
LATEST REVIEWS
Sarepta Therapeutics Inc. (NASDAQ:SRPT) Posts Net Product Revenue Of $121.4 Million...
Sarepta Therapeutics Inc. (NASDAQ:SRPT) has announced its Q3 2020 financial results with net product sales up 23% YoY to $121.4 million.
Sarepta reports 23% YoY...
MAKE IT MODERN
PERFORMANCE TRAINING
Would Summit Therapeutics Inc (NASDQ:SMMT) resort to dilution to raise cash
Summit Therapeutics Inc (NASDQ:SMMT) last traded on Friday at $3.61. The recent surge is attributed to news that it's licensing bispecific antibody...
Aprea Therapeutics Inc. (NASDAQ: APRE) Reports Eprenetapopt Plus Azacitidine Study Results In P53 AML...
Aprea Therapeutics Inc. (NASDAQ: APRE) has announced positive results from the phase II study evaluating eprenetapopt combination with azacitidine as a post-transplant management therapy...
Tiny Apparel Stock that Could be a Big Opportunity in the Making (PVH, FBCD,...
Of all the trends to watch for investors coming out of the pandemic, the apparel industry could be one of the most...
Allogene Therapeutics Inc (NASDAQ: ALLO) Announces Publication of Anti-BCMA CAR T Trial Results
Allogenic Therapeutics Inc (NASDAQ: ALLO) has announced that preclinical trial results for its anti-BCMA CAR T cells have been published in the Cancer Research...
Addentax Group Corp (NASDAQ:ATXG) is surging and could continue here’s why
Addentax Group Corp. (NASDAQ:ATXG) is currently trading at $5.95 up+1.87 (+45.83%). ATXG currently has a 52 week range of $3.81 - $656.54....
MAKE IT MODERN
